therapeutic effects of Carvidelol and Metoprolol in prevention of cardiac arrhythmia after open heart surgery
Phase 3
- Conditions
- Atrial fibrillation.Atrial fibrillation and flutter
- Registration Number
- IRCT2013111015178N2
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
patients indicated for CABG surgery who did not have any contraindications for beta blocker use .Exclusion criteria: chronic obstructive respiratory failure; advanced AV block; previous AF; bradycardia (HR<60); hypotension (SBP<90); ejection fraction<35%; patients who were undergoing repair or replace of heart valve along with their CABG surgery.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atrial fibrillation. Timepoint: During the first 5 days after CABG. Method of measurement: Cardiac monitoring.
- Secondary Outcome Measures
Name Time Method Ventricular fibrillation. Timepoint: During the first 5 days after CABG in ICU. Method of measurement: Cardiac monitoring.